Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT06353958
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 20 and 80 years
* Diagnosed with AMI within 7 days
* Elevated cardiac enzymes (Creatine Kinase-MB or troponin) greater than 2 times the upper limit of normal
* Presence of regional wall motion abnormality
* LVEF ≤ 45% on echocardiography
* Hemodynamically stable
* Not requiring inotropic support
* Systolic blood pressure below 80mm Hg for less than 1 hour
* Resting heart rate above 100 beats/min for less than 1 hour in the past 24 hours
* Peripheral artery oxygen saturation of ≥97%
Exclusion Criteria:
* Pregnancy or breastfeeding
* Positive adventitious infections (such as HIV, hepatitis)
* Need for coronary artery bypass surgery or anticipated further revascularization procedures during the 6-month study period
* Severe aortic or mitral valve narrowing
* Evidence of life-threatening arrhythmia on baseline electrocardiogram (ECG)
* Inability to receive PCI examination or treatment (including New York Heart Association (NYHA) Fc.IV) due to shortness of breath
* Malignant tumor
* Hematopoietic dysplasia
* Other severe organ disease
* Less than 1 year of life expectancy
* Chronic kidney disease with estimated Glomerular Filtration Rate (eGFR)\<20 and/or on renal dialysis
Sex:
ALL
Minimum Age:
41 Years
Maximum Age:
85 Years
Study:
NCT06353958
Study Brief:
Protocol Section:
NCT06353958